Reginaldanderson - Latest News 2026-07-21T16:40:28+00:00 urn:uuid:df27f802-eaa2-ff48-8563-eb6671b74eb7 Warrants Now Available For Health Point Inc. IPO Shares urn:uuid:045b0f0e-359a-a919-1bf3-dedf3852daac 2015-01-20T08:51:45+00:00 Health Point Inc. Advances Stem Cell Research urn:uuid:382ed8a6-26d5-fe58-e0d6-93bff683d929 2015-01-20T08:45:31+00:00 Health Point Inc. Improves Ischemia Treatment urn:uuid:720042e1-bd2d-3608-47d7-184ca2176391 2015-01-20T08:32:37+00:00 Health Point Inc. Announces Service Partners urn:uuid:aca7048b-ce8b-a213-e83a-d497c1cb3ce6 2015-01-16T03:32:52+00:00 Health Point Inc. Angiogenesis Research Progressing Rapidly urn:uuid:ef9024a2-2a9b-9318-e41e-a23313ee9ca9 2014-11-26T09:39:00+00:00 Warrants Available For Health Point Inc. Shares urn:uuid:e4762783-dc91-415d-8a34-871e2ae0dad2 2014-11-26T09:36:46+00:00 Health Point Inc. IPO Price Re-Valued Upwards 50% to $12 urn:uuid:5fd67166-14d6-9418-f6c9-b2db03c2017c 2014-11-26T09:34:16+00:00 First Quarter 2015 Fixed For Health Point Inc. Initial Share Offering urn:uuid:80bf1e6f-b92e-9caa-5bca-7b071efb6ea3 2014-11-25T05:43:40+00:00 Health Point Inc. Immunoassay Facility Endorsed By Top Teaching Hospitals urn:uuid:441f7f56-0aba-5277-1c6a-990b5f8d8e00 2014-11-24T06:49:54+00:00 Health Point Inc. Revolutionary Stem Cell Trials Promotes Vasculogenesis urn:uuid:655ba911-011a-9eb4-bb18-a1ff77acc9a4 2014-11-21T10:58:39+00:00 Health Point Inc. Begins Second Phase Of Lab Expansion urn:uuid:76727a7f-f550-c598-6e36-dedbe8cca960 2014-10-08T11:16:04+00:00 Health Point Inc. Launches Fast Track Genotyping Services urn:uuid:ab2b93b1-64ac-7c16-5337-c9673f9cd156 2014-09-30T07:49:01+00:00 Health Point Inc. Products Increasingly Vital To Vaccine Development urn:uuid:4038ceac-0da7-3683-2100-157ab38b29f9 2014-09-26T03:51:06+00:00 Health Point Inc. Announces Research Partnership For Immunoassay Methods urn:uuid:a3e8e0a1-423b-6853-4e29-a1b3394c5fe6 2014-08-12T04:30:48+00:00 Health Point Inc. Announces Improved Genotyping Services urn:uuid:74eb596d-2bda-1918-2a59-e21e85ee4333 2014-07-28T06:23:21+00:00 Health Point Inc. Continues Planning for IPO urn:uuid:fa6dd0cc-24f0-f070-3acb-b4b8af4e76e8 2014-05-22T03:54:17+00:00 Health Point Inc. Immunoassay Facility Awarded Highest Certification urn:uuid:7b0fbe65-61d6-4113-56c0-302c2f0b5f2d 2014-05-15T04:35:41+00:00 Health Point Inc. Immunoassay Facilities Exceed International Standards urn:uuid:bf42de50-319c-17b0-4089-3baa6d39b6c3 2014-04-09T05:06:13+00:00 Health Point Inc. Documents Stem Cell Links To Improving Angiogenesis Research urn:uuid:b3660b27-0cf5-7bed-0271-f3838e10667a 2014-03-28T08:16:19+00:00 Health Point Inc. Recognized For Life Extending Research urn:uuid:a36ee141-79f2-d884-412a-896b211e5d5f 2014-02-05T06:29:39+00:00 Health Point Inc. Expands Genotyping Facilities urn:uuid:5c0bd67f-35a4-9239-88a0-2e314e7ecaca 2014-01-31T09:23:09+00:00 Health Point Inc. Finalizing Plans For IPO urn:uuid:e423a416-1ec2-f1f6-ed97-2d2608fd4cb6 2014-01-28T07:26:03+00:00 Health Point Inc. Endorses Comprehensive New Quality Policy urn:uuid:f10393d3-f454-e023-6e1b-026abe23b7ed 2014-01-16T03:57:38+00:00 Health Point Inc. A Step Closer To Ischemia Treatment urn:uuid:8b3afa41-2777-ca85-71c6-5a3490f2632a 2014-01-10T02:14:58+00:00 Health Point Inc. Completes Phase One Of Lab Expansion urn:uuid:86ed24e7-1aff-06c4-560f-3a6c53c0fd78 2014-01-05T02:44:21+00:00 Health Point Inc. On Track For Mid 2014 IPO urn:uuid:f939867c-9d43-8840-e1b7-fb874391eda5 2014-01-02T06:31:43+00:00